Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00638651 · ClinicalTrials.gov registry record · Phase 1
Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal
A Phase 1 study, sponsored by University of Miami.
- Completed
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT00638651: Completed Phase 1 study, sponsored by University of Miami.
NCT00638651 is a Phase 1 study that has completed, run by University of Miami. The registered enrollment target is 3 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00638651, a Phase 1 study, has completed, sponsored by University of Miami.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.
Primary Outcome
To evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream (Aldara™, 3M/Graceway Pharmaceuticals, an immune response modifier) in conjunction with the 1064 nm Nd:YAG laser. This procedure for tattoo removal will be compared to laser removal alone.
Interventions
- DEVICE 1064 nm Nd:YAG laser
- DRUG Imiquimod, 5% cream
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2008-02 |
| Est. Completion | 2014-08 |
| Phase | Phase 1 |
What the finished NCT00638651 record still lists
NCT00638651 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 3 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 2 interventions - of which 1064 nm Nd:YAG laser is the first listed.
NCT00638651 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00638651 about?
NCT00638651 is a clinical study titled "Topical Imiquimod in Conjunction With Nd:YAG Laser for Tattoo Removal". The purpose of this study is to evaluate the efficacy of tattoo removal using topical imiquimod, 5% cream in conjunction with the 1064nm Nd:YAG laser. This procedure for tattoo removal will be compared to a laser removal alone.
What is the current status of trial NCT00638651?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2008-02. Estimated completion is 2014-08.
What interventions are being tested in trial NCT00638651?
The interventions under investigation include: 1064 nm Nd:YAG laser (DEVICE), Imiquimod, 5% cream (DRUG).
Who is sponsoring clinical trial NCT00638651?
This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00638651's enrollment target sits among peer trials
3 1999th of 2000 higher than 1 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia